Cerus Corp
NASDAQ:CERS
Cerus Corp
Inventory
Cerus Corp
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cerus Corp
NASDAQ:CERS
|
Inventory
$53.1m
|
CAGR 3-Years
23%
|
CAGR 5-Years
22%
|
CAGR 10-Years
15%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Inventory
$321.2m
|
CAGR 3-Years
8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Inventory
$622.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
14%
|
CAGR 10-Years
31%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Inventory
$228.2m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
28%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Inventory
$62m
|
CAGR 3-Years
21%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Inventory
$326.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
Cerus Corp
Glance View
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The company is headquartered in Concord, California and currently employs 294 full-time employees. The company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, which is based on its technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives, such as plasma, platelets, red blood cells. Its product or product candidates under development includes INTERCEPT Blood System-Platelets, INTERCEPT Blood System-Plasma, INTERCEPT Blood System-Red Blood Cells and INTERCEPT Blood System-Cryoprecipitation. The INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, bacteria and parasites, as well as potentially harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products.
See Also
What is Cerus Corp's Inventory?
Inventory
53.1m
USD
Based on the financial report for Sep 30, 2025, Cerus Corp's Inventory amounts to 53.1m USD.
What is Cerus Corp's Inventory growth rate?
Inventory CAGR 10Y
15%
Over the last year, the Inventory growth was 45%. The average annual Inventory growth rates for Cerus Corp have been 23% over the past three years , 22% over the past five years , and 15% over the past ten years .
